Delivery Order SPE2DB22D9251-SPE2DB25FR1JM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,055.52 to DMS Pharmaceutical Group Inc. for the supply of Omeprazole DR 10 mg capsules (30-count units). This award was issued on August 7, 2025, under a firm fixed-price delivery order contract type with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,055.52 firm fixed-price delivery order is for the supply of Omeprazole DR 10 mg capsules. The contract has a completion date of July 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,583.28 firm fixed-price delivery order is for 4,568,311,491 units of Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of May 21, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Omeprazole DR 10 mg capsules, a prescription medication, with a ceiling value of $4,222.08 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,444.16 firm fixed-price delivery order is for the provision of 4567653313 - Omeprazole DR 10 mg Capsule 30s, a prescription medication. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,111.04, is for the delivery of 4,568,057,868 units of Omeprazole DR 10 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,248.00, is for the delivery of 4,567,792,099 units of the drug Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract, valued at $1,055.52, is for the delivery of Omeprazole DR 10 mg capsules. The contract is a delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
- This is a delivery order award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,583.28 firm fixed-price contract is for the delivery of Omeprazole DR 10 mg capsules. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $1,055.52 contract is for the delivery of 30-count capsules of Omeprazole DR 10 mg. The contract has an ultimate completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in supplying a range of pharmaceutical products, including branded and generic prescription drugs,...
- SPE2DB22D9251Indefinite Delivery Contract
- SPE2DB22D9251-SPE2DB25FR1JMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for Omeprazole DR 10 mg capsules (30-count units) with a ceiling value of $1,319.40. This firm fixed-price delivery order, which is set to be completed by August 29, 2025, represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the company to compete on an unrestricted basis leveraging its woman-owned small business status. This delivery order falls under DMS Pharmaceutical Group's comprehensive $500 million DLA indefinite delivery contract (SPE2DB program, valid through November 2026), which authorizes the agency to issue firm fixed-price delivery orders for a broad range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Omeprazole, a proton pump inhibitor used to treat gastrointestinal conditions, represents one of many prescription medications and over-the-counter pharmaceuticals the company supplies to military health system installations. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains consistent delivery capabilities across diverse product categories including branded and generic drugs, biologics, vaccines, and specialty medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/28/25 |